Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars' Business In North America Ahead of Schedule 2023-09-06 19:00
Biocon Biologics Announces Positive CHMP Opinion for YESAFILI®, Biosimilar Aflibercept 2023-07-24 18:30
Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and Cash 2022-02-28 22:15
1